Search Results 411-420 of 17345 for alopecia

  1. A Phase 1/​2 Study of STP938 for Adult Subjects With Relapsed/​Refractory B-Cell and T-Cell Lymphomas - Mayo Clinic

    - Adequate organ function (bone marrow, hepatic, renal function and coagulation). - All toxicities (except alopecia) from prior cancer treatments or procedures ...

  2. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

    Exception: alopecia. Current use of prohibited medication: Concomitant administration of potent CYP3A4 inhibitors and inducers and moderate CYP3A4 inducers ...

  3. Betamethasone and calcipotriene (topical application route) - Mayo Clinic

    Betamethasone is a corticosteroid (cortisone-like medicine or steroid). It helps relieve redness, pain, itching, swelling, or other discomfort caused by certain ...

  4. Trial of 225Ac-DOTATATE (RYZ101) Alone and with Pembrolizumab in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs (TRACY-1) - Mayo Clinic

    * Any toxicities from prior treatments that have not recovered to CTCAE Grade ≤1, except for alopecia. * Significant cardiovascular disease * Known brain ...

  5. A Study of 177Lu-FAP-2286 in Advanced Solid Tumors (LuMIERE) - Mayo Clinic

    with the exception for alopecia and vitiligo. Exclusion criteria 6 and 7 are removed with Protocol Amendment 7. 8. Impaired cardiac function or clinically ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  9. A Study to Evaluate IMGN632 with Venetoclax and/or Azacitidine to Treat Patients with CD123-Positive Acute Myeloid Leukemia - Mayo Clinic

    Previous treatment-related toxicities must have resolved to Grade 1 or baseline (excluding alopecia). Total white blood cell count must be less than 25 × 10 ...

  10. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.